URGN
UroGen Pharma Ltd. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website urogen.com
- Employees(FY) 192
- ISIN IL0011407140
Performance
-2.51%
1W
-4.62%
1M
-26.81%
3M
-1.56%
6M
-11.93%
YTD
+24.39%
1Y
Profile
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for NMIBC. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Investment Analysis Report: URGN
Overview:
URGN is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $595.5 million. In this report, we will conduct a comprehensive analysis of URGN's financial statements to evaluate its valuation, financial health, earning...
Technical Analysis of URGN 2024-05-31
Overview:
In analyzing the technical indicators for URGN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-06-07 08:00
- 2024-06-06 20:00
- 2024-06-06 08:00
- 2024-06-05 20:00
- 2024-06-05 08:00
- 2024-06-04 20:00
- 2024-06-03 08:00
- 2024-06-02 20:00
- 2024-05-22 08:00
- 2024-05-21 20:00
- 2024-05-14 06:31
UroGen Pharma First Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
- 2024-05-13 20:20
- 2024-05-13 08:00
- 2024-05-13 00:53
- 2024-05-12 21:32
- 2024-05-12 20:00
- 2024-05-12 09:38
- 2024-05-07 08:00
- 2024-05-06 20:00
- 2024-05-05 12:20
- 2024-05-05 00:20
- 2024-05-04 15:20
- 2024-05-04 11:50
- 2024-05-04 03:20
- 2024-05-03 23:50
- 2024-05-03 08:00
- 2024-05-02 20:00
- 2024-04-22 05:29
- 2024-04-17 12:02
- 2024-04-17 00:02
Page 1 of 6
previousnext